Neumora Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	182.53	142.15	374.04	240.94	409.25
Short-Term Investments	-	165.43	79.94	130.94	-
Cash & Short-Term Investments	182.53	307.58	453.98	371.88	409.25
Cash Growth	-40.66%	-32.25%	22.08%	-9.13%	113.17%
Other Current Assets	8.01	6.48	24.3	16.07	6.36
Total Current Assets	190.54	314.06	478.28	387.96	415.6
Net Property, Plant & Equipment	0.46	2.92	6.86	10.64	4.04
Long-Term Investments	-	-	9.85	23.51	-
Other Long-Term Assets	0.05	-	1.21	4.13	9.65
Total Assets	191.05	316.97	496.2	426.23	429.3
Accounts Payable	3.38	3.31	0.34	7.15	1.64
Accrued Expenses	28.79	24.59	21.26	11.54	19.1
Current Portion of Leases	0.28	1.85	3.38	3.37	1.06
Other Current Liabilities	-	0.13	0.14	1.64	1.49
Total Current Liabilities	32.45	29.89	25.11	23.7	23.28
Long-Term Debt	54.53	-	-	-	-
Long-Term Leases	0.19	-	1.85	5.07	1
Other Long-Term Liabilities	-	0.02	0.16	0.63	0.39
Total Long-Term Liabilities	54.73	0.02	2.01	5.7	1.38
Total Liabilities	87.18	29.91	27.12	29.4	24.66
Common Stock	0.02	0.02	0.02	0	0
Additional Paid-in Capital	1,288	1,234	1,173	21.43	11.38
Accumulated Other Comprehensive Income	-	0.06	-0.08	-0.77	-
Retained Earnings	-1,184	-947.22	-703.43	-467.51	-336.61
Minority Interest	-	-	-	843.69	729.86
Shareholders' Equity	103.87	287.06	469.08	-446.85	-325.22
Total Liabilities & Equity	191.05	316.97	496.2	426.23	429.3
Total Debt	55.01	1.85	5.23	8.44	2.05
Net Cash (Debt)	127.52	305.73	448.75	363.44	407.2
Net Cash Growth	-58.29%	-31.87%	23.47%	-10.75%	114.39%
Net Cash Per Share	0.78	1.92	6.90	13.36	18.60
Book Value	103.87	287.06	469.08	-446.85	-325.22
Book Value Per Share	0.64	1.80	7.21	-16.42	-14.85
Tangible Book Value	103.87	287.06	469.08	-446.85	-325.22
Tangible Book Value Per Share	0.64	1.80	7.21	-16.42	-14.85

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q